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Background: Important differences in cardiovascular disease (CVD) mortality by country of birth have been shown within European
countries. We now focus on CVD mortality by specific country of birth across European countries. Methods: For Denmark, England and
Wales, France, The Netherlands, Scotland and Sweden mortality information on circulatory disease, and the subcategories of ischaemic heart
disease, and cerebrovascular disease, was analysed by country of birth. Information on population was obtained from census data or
population registers. Directly age-standardized rates per 100 000 were estimated by sex for each country of birth group using the WHO
World Standard population 2000–25 structure. For differences in the results, at least one of the two 95% confidence intervals did not
overlap. Results: Circulatory mortality was similar across countries for men born in India (355.7 in England and Wales, 372.8 in Scotland and
244.5 in Sweden). For other country of birth groups—China, Pakistan, Poland, Turkey and Yugoslavia—there were substantial
between-country differences. For example, men born in Poland had a rate of 630.0 in Denmark and 499.3 in England and Wales and
153.5 in France; and men born in Turkey had a rate of 439.4 in Denmark and 231.4 in The Netherlands. A similar pattern was seen in
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women, e.g. Poland born women had a rate of 264.9 in Denmark, 126.4 in England and Wales and 54.4 in France. The patterns were similar
for ischaemic heart disease mortality and cerebrovascular disease mortality. Conclusion: Cross-country comparisons are feasible and the
resulting findings are interesting. They merit public health consideration.
. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . ..
Introduction
As a result of post-World War II inward migration Europe has becomea multi-ethnic continent that has substantial populations born
outside its boundaries. This has accelerated legal and policy requirements
to reduce discrimination and promote equity including in its migrant and
ethnic minority populations.1 Planning to achieve this goal, and
demonstrating success, requires information on the health status of
immigrants and their descendants. However, health data by immigration
status and/or ethnic group are sparse across Europe.2 Country of birth, a
direct indicator of migration status, is also the most commonly available
proxy measure for ethnicity in Europe,3 and currently the only one that
can be used to produce epidemiological data for several European
countries simultaneously.2
The MEHO (Migrant and Ethnic Health Observatory, http://www.
meho.eu.com/) demonstration project mapped the availability and
quality of data across the EU in a range of subject areas including car-
diovascular disease (CVD) (work package 6, reported here), cancer and
infection, and developed methods for standardized analyses. The
mapping phase in relation to CVD, which had the express aim of
examining ethnicity related data, showed that relevant data were sparse,
heterogeneous in their quality and methods, but sufficient to allow
limited standardized analyses in a number of EU States.2 Country of
birth was available in 15 of 24 national data sets, while self-reported
ethnic group was only available in five, so we focused our project on
the former. The strengths and weaknesses of these and other indicators in
relation to ethnicity are considered in our earlier article,2 and by Stronks
et al.3
Differences in circulatory diseases, including ischaemic heart disease
(IHD) and stroke (cerebrovascular disease) were demonstrated within
MEHO by country of birth standardized analyses within six European
countries (submitted to DG Sanco). In these analyses, which followed the
approach established in a few European countries,4,5 each country of
birth group has been compared with the population born within the
country. Such analyses have proven to be powerful and have led to
new understanding of public health priorities and avenues for explana-
tory research. For example, such work in England and Wales4,6 has es-
tablished that for mortality, comparative to England and Wales born
groups, populations born in South Asia (India, Pakistan and
Bangladesh) have high rates of IHD and stroke; those born in Africa
and the Caribbean have high rates of stroke; for IHD, the rates have
risen fast and exceeded the England and Wales born groups;6 and those
born in China have low rates of IHD.4 Classical migration studies,
comparing health in the country of origin and in the country of
residence, provide another valuable perspective.7–9
An alternative approach is to compare one country of birth group
across countries to investigate whether outcomes differ by country of
destination. If populations emigrating to different countries are similar
prior to emigration this tackles the question of whether the migrant
population’s disease patterns are affected by local context.
Environmental, demographic and social factors influencing disease
occurrence that are not similarly distributed across countries are likely
to produce such differences. If the disease patterns in such populations
are similar across recipient countries, it suggests the patterns are intrinsic
to the social, cultural and genetic composition of the migrant populations
and their offspring. If, however, a migrant population from one country
(say Turkey) differs by recipient country, we would expect disease
patterns to be different, e.g. if highly qualified migrants were admitted
to one country and unqualified workers were admitted to another. We
explore and focus on this alternative analytical approach, to help assess
whether routine population and mortality data systems should be
developed to facilitate this type of analysis. We offer this article as a
‘test of concept’, fully aware that the empirical data are limited.
Methods
Data
Based on our analysis of the potential availability of suitable data on both
CVD mortality and morbidity across European countries,2 we chose to
study the following EU countries that provided data by country of birth:
Denmark, England and Wales, France, The Netherlands, Scotland and
Sweden. Analyses were in those aged 35–74 years following the recom-
mendations of the EUROCISS Project.10 This restriction was owing to: (i)
few deaths from circulatory disease in people under 35 years of age; (ii)
potentially more inaccuracies in death certification in those over 75 years
of age; (iv) more potential inaccuracies due to return migration to home
countries at older ages; (v) for some ethnic minority groups, younger age
groups may have significant proportions of ethnic minorities born in the
recipient country; and (vi) older populations may have significant
numbers of European groups (born in what were then colonies).
Data on deaths by age (in 5-year age groups), sex, country of birth and
underlying cause of death were acquired. The mortality data were
provided for variable time periods, in some countries being centred on
the 3- to 5-year period around the last Census year (table 1). Data were
extracted using ICD-9 and/or ICD-10 codes as follows: total circulatory
disease ICD9 390–459, ICD10 I00–I99; IHD ICD9 410–414, ICD10 I20–
I25; cerebrovascular disease ICD9 430–438, ICD10 I60–I69.
The Danish and Dutch data sets were longitudinal i.e. people
enumerated at the population register were followed for mortality
through individual linkage to the national death registry (people could
enter or exit the study during follow-up in case of new immigration or
emigration, so this is an open cohort). For these data, the number of
person-years at risk (PYR) in each stratum was computed using the time
of birth, entry onto the population register, and of death or migration, of
each resident.
In Sweden, deaths during the period 2000–06 were obtained annually
from the National Cause of Death Register and PYR from a national
population register. For England and Wales, Scotland and France,
population data by age (5-year age groups), sex and country of birth
were obtained from the most relevant census in each country. For these
countries, PYR was computed multiplying the number of persons in each
stratum at the census by the number of years of observation for deaths.
This approach assumes the denominator size and composition is closed
over the study period.
The following criteria were used to select country of birth groups: (i)
the focus of the MEHO project, which is on predominantly
socioeconomically deprived migrant and ethnic minority populations
originating outside Western Europe and the OECD countries; (ii)
sufficient size of population for meaningful analysis (see below); and
(iii) the particular country of birth group had to be available in at least
two study countries. As a consequence of differences in migration history
and patterns across study countries, the individual country of birth
groups that were analysed differed across countries. We included only
country of birth groups with PYR equal to or greater than 30 000 for men
and women combined as the number of expected events in smaller popu-
lations would mostly be too small for meaningful comparison.
Ethics
As our data were completely anonymized ethical approval was deemed
unnecessary.
Statistical analysis
Directly age-standardized rates (ASR) per 100 000 population for total
circulatory disease, IHD and cerebrovascular disease mortality were
computed for each country of birth group and sex. The WHO
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projected World Standard population 2000–25 was used as the standard.
Precision was estimated using 95% confidence intervals (95% CIs), which
were calculated using a normal approximation and standard errors.11
For findings described as similar there is overlap in the associated 95%
CIs, while in findings described as different the 95% CI do not overlap for
one or more of the comparisons. The CIs are given in the tables in
Supplementary Appendix 1, and for total circulatory disease mortality
also in figures 1 and 2.
Results
Overview of population and death registry data
Table 1 summarizes the features of the available data: two data sets were
longitudinal; most data sets except Denmark (1992–2001) and Sweden
(1990–2006) were over relatively limited time spans around the year 2001;
the PYR of the foreign born population varied greatly but was large in all
countries and often greatly exceeded our cut-off of 30 000.
Total circulatory disease mortality
Men
Figure 1 shows marked variations in male mortality rates in the
local-born populations with the highest in Scotland (372.4) and the
lowest in France (137.2). China born men in France (46.9) had much
lower rates than Scotland and Sweden (145.4 and 154.4, respectively).
India born men in Sweden (244.5) had similar rates to those in
England (355.7) or in Scotland (CIs overlap). Pakistani born men had
similar rates in Denmark, England and Wales and Scotland (518.9, 422.2
and 353.1 with overlapping CIs). Poland born men had extremely high
rates in Denmark (630.0), and England and Wales (499.3), intermediate
in Sweden (287.9) and much lower in France (170.5). Turkey born men
had lower rates in France (153.5) than The Netherlands (231.4), Denmark
(439.4) and Sweden (265.7). Yugoslavia born men had comparatively low
rates in France (183.9) and similar rates in Denmark (313.2) and Sweden
(275.1).
Women
The number of deaths and death rates in women were much smaller than
for men with less precision in estimates. Figure 2 shows that, as for men,
the highest rate in the local born was in Scotland (175.2) and the lowest in
France (46.3). China born women in France (29.6) had much lower rates
than Scotland (140.6) and Sweden (94.4). India born women in England
and Wales, Scotland and Sweden had similar rates (185.5, 161.8 and
152.2). Pakistani born women in Denmark (100.4) had lower rates
than those in England and Wales (238.7) and Scotland (260.0 with
95% CIs overlapping with Denmark). Poland born women had highly
varying rates in Denmark (264.9), England and Wales (126.4), France
(54.4) and Sweden (123.8); and the same applied to Turkey born
women in Denmark (246.3), compared to France (69.1), The
Netherlands (107.6) and Sweden (129.2), with some overlap in the CI
in the latter. Yugoslavia born women had much higher rates in both
Denmark (206.1) and Sweden (136.4) than in France (74.9).
IHD and cerebrovascular disease mortality
As IHD deaths comprise a high portion of all circulatory deaths, the
patterns were very similar to those described above but with less
precision because of smaller numbers, as can be seen in the
Supplementary appendix tables A2 and A3. Cerebrovascular deaths
comprise a small proportion of all circulatory deaths and have slightly
different risk factors and pathophysiology. The numbers of outcomes was
too small for easy interpretation but one clear observation from
Supplementary appendix table A3 is that France born populations had
comparatively low rates in all country of birth groups.
Discussion
Principal findings and key questions arising
Within the MEHO project major inequalities in circulatory diseases,
including IHD and stroke, have been demonstrated by country of birth
analyses within six European countries using data prepared and analysed
in a standardized fashion (Report to DG Sanco 2010). The alternative
Table 1 Overview of study design, time period, number of PYR and number of deaths from circulatory disease by study country
Country and study period PYR for local-born population PYR for foreign-born populations
(35–74 years) Deaths (35–74 years) Deaths
Longitudinal data
The Netherlands, 1996–2006 71766 025 93 839m, 45 031 f Turkey, 1 022 646 869m, 301 f
Denmark, 1992–2001 24888 235 43 467m, 22 260 f Pakistan, 37 598 72m, 9 f
Poland, 52 425 80m, 81 f
Turkey, 72 853 97m, 37 f
Yugoslaviaa, 45 631 44m, 23 f
Non-longitudianal data—variable denominator
Sweden, 1990–2006 57908 351 103 723m, 44 920 f China, 57 545 36m, 24 f
India, 44 968 45m, 22 f
Poland, 404 326 359m, 307 f
Turkey, 247 191 247m, 123 f
Yugoslaviaa, 1 013 075 1216m, 623 f
Non-longitudinal data—fixed denominator
Scotland, 1999–2003 10650 675 22 355m, 12 752 f China, 31 810 19m 16 f
India, 34 630 92m, 36 f
Pakistan, 39 320 59m, 31 f
England and Wales, 1999–2003 106617 055 172 851m, 87 736 f India, 1 588 410 3435m, 1810 f
Pakistan, 842 080 1703m, 794 f
Poland, 128 780 528m, 219 f
France, 2005–07 74653 899 56 228m, 22 782 f China, 82 477 15m, 9 f
Poland, 132 115 91m, 60 f
Turkey, 356 000 207m, 67 f
Yugoslaviaa, 183 497 225m, 81 f
a: Refers to total former Yugoslavia (i.e. Bosnia and Herzegovina, Croatia, Macedonia, Montenegro, Serbia, Serbia and Montenegro or Slovenia) in
Danish and Swedish data but former Yugoslavia (i.e. same as before apart from Bosnia and Herzegovina) in French data.
m = male, f = female
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approach here, comparing the mortality of country of birth groups across
a number of European countries is, to our knowledge, new in Europe.
Our findings warrant further work not only on circulatory diseases, but
also on all-cause mortality and other outcomes, and using other kinds of
data, e.g. prevalence and incidence of morbidity. Conceptually similar
work is underway on cardiovascular risk factor data, in the first
instance trying to harmonize and compare, retrospectively, surveys in
The Netherlands and England.12 That study has examined blood
pressure,12 cigarette smoking,13 obesity,14 diabetes (in press), metabolic
syndrome and exercise patterns (manuscripts in preparation) and shown
how, in some respects, similar ethnic minority groups living in different
European countries differ, possibly reflecting local context.
This work shows that cross-country comparisons of circulatory disease
mortality are potentially valuable for European public health. Many
results accord with prior expectations helping in interpretation, e.g. the
rates are generally much higher in men than women across the
countries.15 The rates are generally lowest in France in all groups, as
previously observed.15 There is no obvious difference in results from
linked and unlinked data sets. The populations previously found to
have high rates, e.g. Indian and Pakistani born, and Eastern European
born,4 have among the highest rates across countries, and those
previously associated with low rates, e.g. the Chinese have among the
lowest rates across countries. Some country of birth groups have
similar ASRs in different countries, e.g. Pakistanis in Denmark,
England and Wales and Scotland. In potentially important ways,
however, the rates vary in some country of birth groups across
countries, indicating that either (i) information systems differ, creating
artefacts or (ii) country-specific context may be important to disease
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outcome or (iii) that differences existed between the same country of
birth groups in differing countries in social circumstances prior to
migration. Notably, while people born outside France, except the
Chinese immigrants, have higher circulatory disease mortality than the
France born, their rates were lower than in their counterparts in other
countries. This observation is considered in more detail below. These
analyses by country of birth are the first to be reported on French data
and will need corroboration.
Both the similarities and differences are of public health and epidemio-
logical interest, pointing to issues around the challenges of disease sur-
veillance, of migration history and local context. A key question is
whether these exploratory analyses justify new efforts in Europe to
create more complete and better validated data systems of this kind.
Strengths and limitations of the work
The strengths of the work include its novelty, topicality and methodo-
logical value in the context of a modern, diverse Europe seeking to tackle
discrimination and inequality, and its development within the multidis-
ciplinary framework of the MEHO project.1,2 It is, however, an early
(probably first) exploration of its kind. The results provide rationale
and motivation for improvement of routine information systems to
allow this kind of analysis in all European countries.16 We used the
indicator country of birth variable as the one best placed for
pan-European work.2,3
The numbers of outcomes were small in some populations with im-
precision reflected in wide CIs but as the immigrant populations age the
number of outcomes will rise. The well-known limitations of this kind of
analysis apply here, e.g. using, as here, country of birth as a proxy
indicator for ethnicity.3,17,18 This is mainly of value for diseases of
older age, such as those studied here, as a high proportion of the
young are born in the country of residence (The country of birth of
the parents can identify these children.)
Mortality data are only one indicator of disease-specific outcomes, but
the quality and quantity of CVD incidence and prevalence data by
country of birth is extremely poor.2 Incidence of acute myocardial
infarction and/or survival after myocardial infarction in immigrants
and ethnic groups has, nonetheless, shown results that are in line with
those here within Sweden,19,20 Scotland21 and The Netherlands.22
Two of our data sets (Denmark, The Netherlands) are based on linked
population and death registers, where the denominator is exact. For
England and Wales, Scotland, Sweden and France this is not so. The
bias arising from mis-measure of country of birth in these independent
data sets is unknown but, as discussed elsewhere in detail, is likely to be
modest because for some causes, e.g. CHD, rates tend to be high, and for
others, e.g. cancers, they are low.17 If the denominator for a country of
birth was seriously underestimated, rates for all diseases would be high.
Some immigrants may die while travelling to or living in their country of
birth, the so-called salmon bias.17 Such biases need to be considered in
data interpretation, particularly across national boundaries but are less
likely to apply to linked databases where there are procedures to capture
movement of residents and their deaths.
Observing variations gives rise to questions, e.g. do variations relate to
socio-economic position, cardiovascular risk factors etc. European data
sets are not yet ready to answer such questions, particularly for lack of
cardiovascular risk factor data by country of birth group. Socio-economic
factors can sometimes be linked to mortality data sets. Scotland has
extracted ethnicity, religion, social and economic indicators from
census records to add to health records but these data were not
available to MEHO because of disclosure controls.23 Risk factor data
were not available in Scotland. New research should seek to develop
these areas.
Access to and utilization of medical care may differ around death by
country of birth. There are no European studies, to our knowledge, of
whether the quality of death certification and coding varies by country of
birth.
Clearly estimates of absolute mortality levels in different countries, as
here, need careful interpretation due to between-country differences in
population coverage, study period and study design. The Swedish data
span 18 years, e.g. while the French data are for 3-years. This matters for
diseases, as here, where there are time trends.
Interpretation of the results in the light of the literature—
the concept, findings and French
(North–South/Mediterranean) Paradox
Sizeable variations in circulatory mortality by country of birth have been
demonstrated in England and Wales for some decades4,6,24 and more
recently in The Netherlands,5 and Scotland.25 In Sweden, important dif-
ferences have been seen for myocardial infarction incidence.20 The
finding here that rates of disease for one country of birth group appear
to vary, sometimes quite substantially, across different countries in
Europe suggests that disease outcomes may be influenced by the local
context, whether this is health care, diagnostic methods and coding, avail-
ability of data in surveillance systems, social and economic standing,
stress, lifestyle, migration history, social circumstances and health prior
to migration or other environmental factors. These variations are
extremely unlikely to be genetic. We consider such issues by focusing
on France.
France has a reputation as a place where circulatory diseases are sur-
prisingly uncommon, despite a high prevalence of traditional risk factors,
e.g. cigarette smoking26 and a high-fat diet,27 and one that, similar to
other countries, does not conform to current guidelines.28,29 This has led
to the phrase ‘the French paradox’.29 Other Southern European countries
also have low rates,15 giving rise to the terms North–South and
Mediterranean Paradoxes. Miscoding and misclassification are
considered likely, but even after corrections, the rates in France remain
comparatively very low.29,30 [All-cause mortality is not comparatively low
in men in France compared to other European countries (and higher than
in England and Wales), as might be expected given truly very low rates of
circulatory disease.15] A global review pointed to two key hypotheses i.e.
to high consumption of alcohol, particularly wine, and a time-lag effect,
whereby the effects of high-fat diet are still to come.31 In this study,
compared with those who were born in France, people born outside
France (from a wide range of countries) had high rates of circulatory
diseases. Indeed, the differences by country of birth within France were
similar to those seen within other European nations. We also saw that
people born outside France have relatively low rates compared to their
counterparts in other countries. (No other Southern European countries
were compared here and that should be interesting.) Despite the substan-
tial differences within France, the French paradox seemingly applies to
people born outside France but living there.
It is unlikely that apparently protective aspects of French alcohol con-
sumption patterns or diet have transferred to a wide-range of migrant
groups—China, Poland, Turkey and Yugoslavia born. For example, the
Turkish born are unlikely to have taken on red wine drinking in the
French style. Turkey is a secular country where there is modest consump-
tion of alcohol by a minority (especially low in women). Data from The
Netherlands shows no evidence for major convergence to the alcohol use
patterns of the majority Dutch population. In 2004, in Amsterdam,
74.8% of 189 Turkish men reported total abstinence compared with
9.5% of Dutch men.32 While methods of data collection affect results,
the prevalence of alcohol use was low by all methods, in the study by
Dotinga et al.33 We found no recent data from France but work in 1992
indicated 49% of Turkish men and 69% of women considered alcohol
forbidden.34
These observations raise new questions about, and approaches to,
study of the French Paradox. These questions will be both on the
potential role of differences in death certification and, assuming these
are not explanatory, the potential proactive factors, which may not be
either alcohol or diet, given these findings.
Further work to explain the kind of patterns seen across the six
countries will need to access information on populations’ circumstances
prior to migration and in the countries of residence, including data on
social and economic circumstances, healthcare and risk factors. The
approach here adds to classical migrant studies where, most usually,
one migrant population is followed-up after migration in its new
country of residence, or it is compared with populations continuing to
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reside in the countries of origin.7 One of the best known such studies is
the NI-HON-SAN Study of Japanese in Japan, Honolulu and San
Francisco.8 It demonstrated convergence of cardiovascular risks and
risk factors among migrants, and showed the protection against such
diseases by maintenance of traditional behaviours rather than rapid ac-
culturation. Recent work in this tradition includes Mbanya et al.’s study
showing glucose intolerance and obesity levels in West African popula-
tions in Cameroon were lower than in corresponding populations in
Jamaica and the UK, reflecting higher levels in the recipient
population.35 A recent review of cancer in non-western migrants to
Europe judged that cancer risks were between those in the country of
origin and recipient country.36 Our data, from 6 countries of origin,
showing both similarities and differences across countries, also point to
such changes and call for studies to examine how immigrant populations
are adapting the lifestyles associated with their countries of adoption.
Conclusion
Our work explores new territory in the field of inequalities in disease
mortality within and between countries in Europe. Future work needs to
extend the range of countries (particularly, more countries from
Southern and Eastern Europe), the sample sizes and follow-up periods,
improve the validity of population data outside census years, move to
more emphasis on linked data sets and refine the methods to maximize
comparability. Europe needs to consider whether, and if so how, to move
from country of birth, a proxy that will not be valid for most descendants
of migrants in European countries, to other measures of ethnic group, so
that we can track change across several generations.17 As we see from the
example of the Roma (Gypsy Traveller) populations, migrants to Europe
over the last 700–1000 years, there is no automatic convergence over
time37—long-term public health surveillance is needed.
Studies of this kind can generate information to develop healthcare and
public health interventions and services, and also generate hypotheses
into the causes, consequences and control of diseases.16 Insights from
populations with very low rates of CVD morbidity and mortality, such
as the Chinese born, will be of particular interest in informing public
health initiatives designed to minimize death and disability from circu-
latory diseases in Europe. This article provides evidence in favour of a
coordinated European effort that builds on and extends the national
systems already in place to permit a better examination of country of
birth and/or ethnic variations in disease and death. It is time to confront
the challenge.16
Supplementary data
Supplementary data are available at Eurpub online.
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Key points
 Differences in mortality by country of birth have been
demonstrated previously within several European countries.
 Whether the mortality of particular country of birth groups
differs across European countries is unknown.
 We undertook new analyses as a test of concept in six EU nations.
 This exploratory study shows sufficient differences of interest
across countries to warrant both further research, and
refinement of surveillance systems, to permit such analyses
across Europe.
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Measuring vaccination coverage in a hard to reach minority
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Background: Although childhood vaccination programmes have been very successful, there are some hard to reach minority groups that
object to vaccination. The Netherlands has experienced several epidemics of vaccine-preventable diseases, confined to the orthodox
Protestant minority. However, vaccination coverage in this minority is still unknown and this hampers prevention and control of
epidemics. Methods: We estimated vaccination coverage among the orthodox Protestant minority and its various subgroups (denomin-
ations), using two sub-studies with different design and study population. For both sub-studies separately, we determined overall vaccin-
ation coverage and vaccination coverage per denomination. The results were compared and discussed. Results: An online survey was filled
out by 1778 orthodox Protestant youngsters, invited via orthodox Protestant media using a snowball method. Next to that, results of a
national sample study on vaccination were used, of which only orthodox Protestant respondents were included in our analyses (N = 2129).
Overall vaccination coverage among orthodox Protestants in The Netherlands was estimated to be at minimum 60%. Moreover, in both
sub-studies three clusters of denominations could be identified, with high (>85%), intermediate (50–75%) and low (<25%) vaccination
coverage. Conclusion: The integration of both sub-studies, with their own specific strengths and weaknesses, added to our insight in the
vaccination coverage in this minority. Based on these results, we recommend to focus prevention and control of vaccine-preventable diseases
on the orthodox Protestant subgroups with intermediate and low vaccination coverage.
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Introduction
Childhood vaccination programmes have been very successful incontrolling infectious diseases. However, even in affluent societies
like in Western Europe, there are minority groups with low vaccination
coverage.1 Some marginalized groups are not sufficiently reached by vac-
cination programmes2–4 and an increasing number of parents refuse
vaccination because of philosophical objections and safety concerns.5
Social clustering of unvaccinated children may lead to outbreaks of
vaccine-preventable diseases.6 The last decades The Netherlands has
experienced epidemics of poliomyelitis, measles, rubella and mumps, all
largely confined to an orthodox Protestant minority with religious
objections to vaccination.7–10 These objections find their origin in the
trust in Divine providence. God has predestined health and disease and
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